Our cancer care system IS in crisis, and …

… the situation is laid out in some detail in an article by Payne and Dale on the Health Affairs blog site. Additional commentary can be found on the Medscape Oncology site. … READ MORE …

Chimeric antigen receptor T-cell (CART) therapy: current data, future potential

An article in today’s issue of the New England Journal of Medicine reports data from a Phase II trial of CART therapy in the treatment of patients with acute lymphoblastic leukemia or ALL (an aggressive and difficult to treat form of cancer). This is arguably one of the most exciting papers on the treatment of cancer in the past 50+ years. … READ MORE …

Bayer, Orion initiate Phase III trial of ODM-201 in non-metastatic CRPC

According to a media release today from Bayer HealthCare and Orion Corporation (a Finnish pharmaceutical company), they have started to  enroll patients in a randomized Phase III clinical trial of ODM-201, a novel, oral androgen receptor inhibitor in development for the treatment of men with advanced forms of prostate cancer. … READ MORE …

Mortality, body mass index, and Gleason score: the relationship

New data appear to suggest that you really don’t want to be diagnosed with high-risk prostate cancer if you are significantly over-weight or obese. … READ MORE …

Development of prostate cancer “organoids” may facilitate next-gen research

Researchers at Weill Medical College and at Memorial Sloan-Kettering Cancer Center in New York have worked out how to grow “organoids” from metastatic prostate cancer tissue. This may be important for the clinical testing of new types of treatment and (later on) for the ability to determine which drugs work well in individual patients. … READ MORE …

Educating newly diagnosed men about their prostate cancer before treatment

There is a short but simply outstanding article in this month’s issue of ASCO Connection by Anne Katz — a specialized oncology nurse who works up in Winnipeg, Manitoba. It deals with the conversations she has, often several times a day, with newly diagnosed prostate cancer patients at her institution. … READ MORE …

Do you have Stage IV or metastatic prostate cancer?

We understand that Health Monitor magazine is looking for a few men with Stage IV or metastatic prostate cancer (and possibly their spouses/partners) who are willing to be professionally interviewed. The magazine has a tight timeline. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,153 other followers